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Abstract
Campylobacter jejuni (C. jejuni ), a Gram-negative 
microaerophilic bacterium, is a predominant cause 
of bacterial foodborne gastroenteritis in humans 
worldwide. Despite its importance as a major foodborne 
pathogen, our understanding of the molecular 
mechanisms underlying C. jejuni  stress survival and 
pathogenesis is limited. Inorganic polyphosphate (poly 
P) has been shown to play significant roles in bacterial 
resistance to stress and virulence in many pathogenic 
bacteria. C. jejuni  contains the complete repertoire of 
enzymes required for poly P metabolism. Recent work in 
our laboratory and others have demonstrated that poly 
P controls a plethora of C. jejuni  properties that impact 
its ability to survive in the environment as well as to 
colonize/infect mammalian hosts. This review article 
summarizes the current literature on the role of poly P 
in C. jejuni  stress survival and virulence and discusses 
on how poly P-related enzymes can be exploited for 
therapeutic/prevention purposes. Additionally, the 
review article identifies potential areas for future 
investigation that would enhance our understanding 
of the role of poly P in C. jejuni  and other bacteria, 
which ultimately would facilitate design of effective 
therapeutic/preventive strategies to reduce not only the 
burden of C. jejuni -caused foodborne infections but also 
of other bacterial infections in humans.
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Core tip: Recent studies show that inorganic poly-
phosphate (poly P) plays several important roles in 
the biology of Campylobacter jejuni (C. jejuni ), a 
major cause of bacterial foodborne gastroenteritis in 
humans. This review summarizes the latest findings 
on the role of poly P in C. jejuni  stress survival and 
virulence, provides directions for future investigation, 
and discusses the potential of polyphosphate kinase 
enzymes as drug/vaccine targets to control C. jejuni  
infections in humans.
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INTRODUCTION
Campylobacter (Greek word “Kampylos” means 
curved) species are curved to spiral-shaped, non-
spore forming, Gram-negative bacteria that contain 
a single flagellum at one or both ends. Most of the 
Campylobacter species are microaerophilic and use a 
respiratory type of metabolism; however, some species 
prefer to grow anaerobically. Campylobacter species are 
chemoorganotrophs - they primarily depend on amino 
acids or Kreb’s cycle intermediates for energy. Based 
on their optimal growth temperature, Campylobacter 
species are classified into thermophilic and non-
thermophilic species. The thermophilic Campylobacter 
species grow optimally at 42 ℃ [Campylobacter jejuni 
(C. jejuni) and Campylobacter coli (C. coli)], while 
the non-thermophilic species grow optimally at the 
range between 30-37 ℃ (Campylobacter fetus). The 
genus Campylobacter consists of 34 species and 14 
subspecies, which are human and animal pathogens 
(http://www.bacterio.net/campylobacter.html, last 
accessed 17 March 2016). Several of these species 
cause a plethora of clinical manifestations in humans 
(Table 1); however, C. jejuni and C. coli are the predo-
minant species associated with human disease[1].
C. jejuni is one of the major causes of bacterial 
foodborne diarrheal disease in the United States 
and worldwide[2]. According to Foodborne Diseases 
Active Surveillance Network, Campylobacter spp. 
account for 9% of total foodborne illnesses, 15% of 
hospitalizations and 0.1% of deaths from foodborne 
illnesses each year[3]. In immunocompetent patients, 
C. jejuni infection typically manifests as a self-limiting 
acute gastroenteritis characterized by severe watery 
and sometimes bloody diarrhea, fever, nausea, and 
vomiting. However, in immunocompromised patients, 
C. jejuni can cause a severe, life-threatening disease, 
often requiring hospitalization and antibiotic treatment. 
In addition to causing gastroenteritis, C. jejuni is 
also associated with post-infection complications 
such as Guillain-Barre syndrome, which is a rare 
neuromuscular disease that is thought to occur in 1 
in 1000 individuals infected with C. jejuni[4]. Other 
sequelae such as Reiter’s syndrome, inflammatory 
bowel syndrome, and immunoproliferative small 
intestinal disease also significantly add to the burden 
of C. jejuni infection[5-7]. 
Unlike in humans, C. jejuni lives as a commensal 
in the gut of a variety of domestic and wild animals 
and birds[4]. Epidemiological studies show that the 
majority (50%-80%) of human infections are acquired 
by consumption of contaminated poultry and poultry 
products and that nearly 90% of the poultry flocks 
in the United States are colonized with C. jejuni, 
suggesting that controlling C. jejuni colonization in 
poultry is an effective strategy to control human 
infections[4]. Rarely, contaminated raw milk, water, 
and vegetables also serve as sources of human 
infection[1,4]. Although transmission through ingestion 
of contaminated food and water is the major route, 
person-to-person contact, as well as contact with pets 
or their feces is not uncommon[1,4]. Although C. jejuni 
is a major public health concern worldwide, the genetic 
determinants that contribute to its ability to survive in 
different host and non-host environments, to colonize 
poultry and other domestic animals, and to cause 
disease in humans are relatively poorly understood.
C. jejuni is unique among the enteric bacterial 
pathogens in that it lacks many classical stress 
response and virulence mechanisms. More specifically, 
C. jejuni lacks the stationary phase sigma factor RpoS, 
the heat shock sigma factor RpoH, the cold shock 
protein CspA, the oxidative stress response genes 
SoxRS, OxyR, SodA and KatG, the osmoprotectants 
ProU, OtsAB and BetAB, and the leucine-responsive 
global regulator Lrp, which are all essential for 
stress tolerance in other enteric pathogens[8]. These 
findings are consistent with the unusual sensitivity 
of C. jejuni to various environmental stresses i.e., C. 
jejuni is unable to grow in the presence of oxygen, 
has a narrow growth temperature range, is normally 
incapable of multiplication outside the host, does not 
survive well on dry surfaces, cannot withstand high 
temperaturature, and is more sensitive to osmotic 
and low pH stresses[8]. C. jejuni also lacks many 
classical virulence mechanisms, including a type Ⅲ 
secretion system and exotoxins, which play important 
roles in the pathogenesis of other enteric bacteria[9]. 
Several C. jejuni strains contain type Ⅳ and type Ⅵ 
secretion systems but the absence of these systems 
in many pathogenic C. jejuni strains questions 
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their requirement for virulence[10,11]. Nevertheless, 
the increasing incidence of C. jejuni infections in 
humans suggests that this organism may have 
evolved alternative mechanisms for stress survival 
and virulence. One such mechanism that has been 
relatively well characterized by several recent studies 
and plays important roles in C. jejuni survival and 
virulence involves inorganic polyphosphate (poly P). In 
this review, we summarize recent data on the role of 
poly P and related enzymes in C. jejuni biology, with 
particular focus on stress survival and virulence.
INORGANIC POLYPHOSPHATE
Even after the discovery of the subatomic particle 
(the God particle), the origin of the universe is still a 
debated topic. However, there is almost a universal 
agreement that phosphate has played a key role in 
the origin of life on earth. Poly P is a linear polymer 
of ten to hundreds of phosphate residues linked by 
high-energy phosphoanhydride bonds. Poly P granules 
were first seen in bacteria as “Volutin granules” or 
“Metachromatic granules”, named after their tendency 
to stain pink with basic blue dyes[12]. Indeed, the 
presence of metachromatic granules was used as a 
diagnostic feature for pathogenic bacteria such as 
Corynebacterium diptheriae. Later with the advent of 
electron microscopy, these granules were identified 
in nonpathogenic bacteria, which refuted the idea 
of using poly P granules as a marker for pathogenic 
bacteria[12]. Recent studies have shown that poly P is 
essential for numerous cellular functions in bacteria, 
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Table 1  Comprehensive summary of Campylobacter  infections in humans
Type Clinical form/presentation Risk factors Target site Symptoms Species associated
(A) Intestinal Periodontal diseases Oral bleeding, increased 
vascular permeability[70], and 
pregnancy[71]?
Oral cavity Bleeding, tenderness, and tooth 
loss
C. rectus[70], C. gracilis, 
C. showae[72] and C. 
concisus[73]
Esophageal diseases Mucosal damage due 
to stomach contents 
regurgitation[1] 
Esophagus Heart burn, regurgitation, bloating, 
bad breath, nausea, and abdominal 
pain
C. concisus[74]
(gastroesophageal 
reflux disease, Barrett’s 
esophagus, and esophageal 
adenocarcinoma)
Self-limited gastroenteritis, 
most common form 
All factors as described in 
review
Jejunum and 
ileum
Diarrhea, fever, and abdominal 
pain
C. jejuni and C. coli[1,75]
Post-infectious functional 
gastrointestinal disorder, 
irritable bowel syndrome, 
and functional dyspepsia
Infection with C. jejuni and 
other species[1]
Diarrhea, constipation or both, and 
abdominal pain
C. jejuni, C. coli and C. 
consisus[76]
Inflammatory bowel disease, 
Crohn’s diseases (CD), and 
ulcerative colitis (UC)
Gut dysbiosis[77] CD-any part of 
intestine
UC- colon
Diarrhea, fever and fatigue, 
abdominal pain, weight loss, and 
reduced appetite
C. concisus, C. showae, C. 
hominis, C. rectus, and C. 
ureolyticus[78]
Colorectal cancer Gut dysbiosis[79] Colon Diarrhea, constipation, abdominal 
pain, weight loss, and rectal 
bleeding
C. showae[80]
Cholecystitis Gall stones[1] Gall bladder Pain and tenderness in right 
abdomen, nausea, vomiting, and 
fever
C. jejuni[81]
(B) Extra-
intestinal
Guillain-Barre syndrome C. jejuni infection[82] Nervous system Progressive symmetric weakness 
in limbs, below or lack of reflex 
(hyporeflexia)
C. jejuni[1,82]
Miller Fisher syndrome C. jejuni[83] Nervous system Oculo-motor weakness C. jejuni[83]
Reactive arthritis Infection with enteric 
bacterial pathogens, 
including Campylobacter[84]
Joints, eyes, and 
genitourinary 
tract
Pain and stiffness of joints, swollen 
toes, eye inflammation, and 
urinary problems
C. jejuni and C. coli[1,84]
Cardiovascular 
complications
Immuno-compromised 
condition, and bacteremia[1]
Cardiovascular 
system
Chest pain leading to arrhythmia, 
dilated cardiomyopathy, and 
sudden death due to congestive 
heart failure
C. jejuni and C. fetus[85,86]
Meningitis Immuno-compromised 
condition[1,87]
Meninges of 
brain and spinal 
cord
Headache with nausea or 
vomiting, seizures, sensitive to 
light, and loss of appetite 
C. jejuni and C. fetus[88,89]
Abscesses of breast, brain, 
vertebra, and liver
Secondary bacterial infection Breast, brain, 
vertebra, and 
liver
Varies with target organ C. rectus[90], C. curvus, C. 
gracilis and C. showae[91]
Reproductive complication Bowel infection, and 
periodontal disease[92] 
Uterus, and 
placenta
Preterm birth, low birth weight, 
and intra-uterine growth 
restriction 
C. jejuni, C. coli, C. fetus 
and C. upsaliensis[92]
Campylobacter infection types, clinical presentations, risk factors, target organ or tissues involved, symptoms and associated Campylobacter species are 
described.
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P to inorganic phosphate[13,21]. Many bacteria contain 
2 types of exopolyphosphatases[22], one that only 
hydrolyzes poly P (hereafter referred to as PPX) and 
the other that, in addition to hydrolyzing poly P, also 
hydrolyzes guanosine pentaphosphate (pppGpp) to 
guanosine tetraphosphate (ppGpp) (hereafter referred 
to as PPX/GPPA)[13,23]. ppGpp is a signaling molecule 
that plays an important role in bacterial stringent 
response induced by starvation[13,23]. Of all the poly 
P-metabolizing enzymes, PPX enzymes are the least 
understood with regards to their role in bacterial 
survival and virulence. 
POLY P METABOLISM IN C. JEJUNI
C. jejuni contains all the enzymes involved in poly P 
metabolism- PPK1, PPK2, and 2 PPX/GPPA enzymes 
(Figure 1). Two independent studies have evaluated 
the contribution of PPK1 to poly P metabolism in 
C. jejuni[24,25]. Using a toluidine blue O assay, both 
studies demonstrated that the C. jejuni wildtype strain 
accumulated more poly P in stationary phase than 
in mid-log and transition phases and that deletion of 
ppk1 significantly reduced poly P accumulation (Figure 
1)[24,25]. The C. jejuni ppk1 mutant retained a modest 
ability to synthesize poly P[24,25]; thus, the alternative 
enzyme that contributes to residual poly P levels in the 
ppk1 mutant remains to be identified. Using electron 
microscopy, the authors further demonstrated that 
the C. jejuni wildtype strain contained several poly 
P-like granules and that the ppk1 mutant contained 
fewer of these granules[25]. More recently, a detailed 
ultrastructure analysis of C. jejuni at 5 nm resolutions 
also showed the presence of orange, poly P storage 
granules in C. jejuni[26]. Although the two studies 
suggested that the observed granules are poly P 
granules, additional work is required to confirm that 
such as energy source, phosphate reservoir, cation 
sequestration, buffering role against alkali, participation 
in membrane transport, cell envelope formation and 
function, regulator of enzyme activities, gene activity 
control and development, chromatin destabilization, 
DNA replication and phage production, sporulation and 
germination, bacterial virulence/pathogenesis, and 
regulator of stress and survival[13]. Additionally, bacteria 
capable of storing large amounts of intracellular poly P 
are used in the biological treatment of wastewater[14].
GENERAL ASPECTS OF POLY P 
METABOLISM IN BACTERIA 
Polyphosphate kinase 1 (PPK1) is the principal enzyme 
responsible for poly P synthesis in many bacteria[15,16]. 
PPK1 is highly conserved; homologs of this enzyme 
have been found in over 100 bacterial species, 
including 20 major human and animal pathogens. 
PPK1 is perhaps the most known of all poly P-related 
enzymes for its role in bacterial survival under 
conditions of stress, virulence, and host colonization[13]. 
Many bacterial species contain another enzyme, 
PPK2, which preferentially mediates poly P-driven 
generation of guanosine triphosphate (GTP)[17,18], 
a molecule known to have important roles in cell 
signaling and DNA, RNA, protein, and polysaccharide 
synthesis[19,20]. Similar to PPK1, PPK2 is also widely 
conserved in bacteria, including major human 
pathogens such as Mycobacterium tuberculosis, 
Pseudomonas aeruginosa, and Vibrio cholerae among 
others[17]. Although relatively less studied compared 
to PPK1, few recent studies have shown a role for 
PPK2 in bacterial survival and virulence[18]. The third 
family of enzymes involved in poly P metabolism 
includes exopolyphosphatases, which degrade poly 
Figure 1  Model of poly P metabolism in Campylobacter jejuni. Phosphate esters are hydrolyzed to inorganic phosphate (Pi) by alkaline phosphatase (PhoAcj) 
in the periplasm. Phosphate uptake proteins and alkaline phosphatase are directly regulated by the PhosS/PhosR two-component system. Pi is transported across 
the inner membrane via the high affinity phosphate transport system PstSCAB. ATP generated from Pi is utilized for poly P synthesis by PPK1. PPK2 utilizes poly P 
to generate GTP, while PPX hydrolyzes poly P back to Pi. PPX also affects conversion of (p)ppGpp to ppGpp. SpoT is a bifunctional enzyme involved in both ppGpp 
synthesis as well as ppGpp hydrolysis. SpoT is also linked to poly P metabolism and a spoT mutant has reduced ability to accumulate poly P. 
Phosphate esters
PhoAcj Phosphate limitation
PhosS
Outer membrane
Periplasm
Inner membrane
Cytoplasm
Pi
PhosR
PstSCAB
Pi
nATP
PPK1 PPK2
GTP
PPX
(p)ppGpp
ppGpp
GDP + PPi
SpoT
Poly P(n-1) + Pi
Poly P
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these granules are indeed poly P granules.
In another study, the role of PPK2 in poly P 
metabolism was investigated[27]. The authors of this 
study demonstrated that a ppk2 mutant was deficient 
in poly P-dependent GTP synthesis. The authors also 
showed that the ratio of ATP:GTP was altered in the 
ppk2 mutant, thus suggesting that PPK2 is required 
for poly P-dependent GTP synthesis as well as for 
maintenance of nucleotide balance in the cell (Figure 
1). GTP is a signaling molecule that modulates many 
physiological functions in bacteria[19,20]. Unlike studies 
in other bacteria, which showed that PPK2 possesses 
poly P-synthetic activity[28], the authors demonstrated 
that poly P levels were unaltered in the C. jejuni ppk2 
mutant when compared to wildtype, suggesting that 
PPK2 does not appear to contribute to poly P synthesis 
in C. jejuni[27].
Malde et al[29] evaluated the contributions of PPX/
GPPA enzymes to poly P metabolism in C. jejuni. They 
demonstrated that both ppx1/gppa and ppx2/gppa 
mutants accumulated more poly P than the wildtype 
strain and that the ppx1/gppa mutant accumulated 
relatively more poly P than the ppx2/gppa mutant 
when compared to wildtype. Based on these data, 
the authors suggested that PPX1/GPPA and PPX2/
GPPA are involved in poly P degradation and that 
PPX1/GPPA is probably the primary enzyme that 
contributes to poly P degradation in C. jejuni (Figure 
1)[29]. However, whether PPX/GPPA enzymes possess 
PPX activity needs to be further experimentally 
confirmed.
PPKS: ROLE IN C. JEJUNI SURVIVAL 
AND VIRULENCE
Mutations in ppk1 and ppk2 genes have resulted in a 
variety of phenotypic changes in C. jejuni. Although 
the mechanisms underlying these phenotypes are 
poorly understood, the phenotypes as such are 
significant and relevant to C. jejuni pathogenesis. 
In the following sections, we will review our latest 
understanding of the role of PPKs in these phenotypes, 
which are summarized in Table 2.
PPKs: Role in growth and stationary phase survival
Several studies evaluated the effect of ppk1 and ppk2 
mutations on C. jejuni growth and demonstrated that 
these mutations do not affect C. jejuni growth[24,25,27]. 
In other organisms, ppk1 mutants are defective in 
stationary phase growth and survival[30,31]. The C. jejuni 
wildtype strain accumulated more poly P in stationary 
phase than in mid-log and transition phases and 
more genes were differentially expressed in the ppk1 
mutant in stationary phase when compared to mid-
log phase[24,25,32]. However, the C. jejuni ppk1 mutant 
grew and survived similar to wildtype in stationary 
phase. A possible explanation for this difference is 
that C. jejuni lacks RNA polymerase, sigma S (RpoS), 
which regulates stationary phase survival and itself is 
modulated by poly P in other organisms[8,33].
PPKs: Role in stress survival and adaptation
C. jejuni encounters a number of unfavorable 
Table 2  Phenotypes associated with enzymes of poly P and ppGpp metabolism
Phenotype PPK1 PPK2 PPX1 PPX2 PPX1-PPX2 PhoAcj SpoT
Poly P metabolism
   Poly P synthesis/accumulation ↑ - - - - ↑ ↑
   Poly P-dependent GTP synthesis - ↑ NT NT NT NT NT
   Poly P degradation - - ↑ ↑ ↑ NT NT
   Maintenance of ATP:GTP ratio NT ↑ NT NT NT NT NT
ppGpp metabolism
   ppGpp synthesis NT - ↑ - ↑ NT ↑
Stress survival
   Stationary phase survival and growth - - - - - - ↑
   Survival under low CO2 NT NT NT NT NT NT ↑
   Osmotic shock survival ↑ ↑ ↑ ↑ ↑ ↑ NT
   Low nutrient stress survival ↑ ↑ ↑ ↑ ↑ ↑ NT
   Aerobic stress survival - ↑ NT NT NT NT ↑
   VBNC formation ↑ ↑ NT NT NT NT NT
   Natural transformation ↑ NT NT NT NT NT NT
   Antimicrobial resistance ↑ ↑ NT NT NT ↓ R
Virulence-related
   Motility - - ↑ ↑ ↑ NT NT
   Biofilm formation ↓ ↓ ↑ ↑ ↑ ↓ NT
   Resistance to complement-mediated killing NT NT ↑ ↑ ↑ NT NT
   Adherence NT - NT NT NT NT ↑
   Invasion - ↑ ↑ ↑ ↑ ↑ ↑
   Intraepithelial survival ↑ ↑ ↑ ↑ ↑ ↑ ↑
   Chicken colonization ↑ ↑ NT NT NT ↑ NT
NT: Not tested; R: Tested only for Rifampicin resistance; -: Phenotype absent; ↑: Phenotype is positively regulated i.e., deletion of the gene reduces the 
phenotype when compared to wildtype; ↓: Phenotype is negatively regulated i.e., deletion of the gene enhances the phenotype when compared to wildtype.
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environments both in the external environment during 
transmission as well as in the host during colonization/
infection[8]. Poly P is known for its role in modulating 
stress tolerance in bacteria[13]. Two independent 
studies by Candon et al[24] and Gangaiah et al[25] 
demonstrated that the ppk1 mutant had a reduced 
ability to survive under low nutrient stress and osmotic 
shock. Similarly, in another study, Gangaiah et al[27] 
showed that the ppk2 mutant, in addition to displaying 
a reduced ability to survive under low nutrient stress 
and osmotic shock, also had reduced ability to survive 
under aerobic stress. Bacteria generally respond 
to nutrient stress by eliciting a stringent response 
regulated by ppGpp and/or a general stress response 
regulated by RpoS. A C. jejuni bifunctional (p)ppGpp 
synthase/hydrolase (spoT) mutant, which is defective 
in eliciting a stringent response, was compromised 
in its ability to survive under low nutrient stress[34]. 
Thus, to rule out the possible role of ppGpp in PPK1-
mediated nutrient stress survival phenotype, it would 
be interesting to determine if ppGpp levels are altered 
in the ppk1 mutant. Transcriptome analysis revealed 
that, despite C. jejuni lacking RpoS, homologs of 
several genes involved in general stress response 
were downregulated in ppk1 and ppk2 mutants; this 
might partly explain the stress survival deficiencies 
in the ppk mutants[32]. In E. coli, poly P also affects 
stress tolerance by several other mechanisms- poly P 
is thought to be involved in sensing minor changes at 
the cell surface, serves as a source of energy during 
times of stress, and regulates Lon protease, which 
degrades nonessential proteins providing free amino 
acids for survival during stress[13,35-38]. Whether such 
mechanisms also play a role in poly P-mediated stress 
resistance in C. jejuni is worth investigating.
PPKs: Role in viable but nonculturable cell formation
C. jejuni is also capable of forming viable but 
nonculturable cell (VBNC) under stressful conditions; 
this phenotype is thought to provide a survival 
advantage to C. jejuni during times of stress[39,40]. 
Two recent studies showed that both ppk1 and ppk2 
mutants were compromised in their ability to form 
VBNCs after formic acid treatment[25,27]. The reduced 
ability of the ppk mutants to form VBNCs could be due 
to the fact that these mutants were more sensitive 
to other stresses such as low nutrient stress and 
osmotic shock. Poly P can serve as a source of energy 
during times of stress[13]; this could also contribute 
to the reduced ability of the ppk1 mutant to form 
VBNCs. A ppk2 mutant had similar poly P levels but 
was compromised in its ability to regulate nucleotide 
balance; thus, whether altered nucleotide balance 
is the cause of the ppk2 mutant’s reduced ability to 
form VBNCs needs to be further studied. One might 
also speculate that PPK enzymes, as global regulators, 
might modulate VBNC formation by affecting the 
expression of other genes involved in VBNC formation; 
however, transcriptome analysis of ppk mutants did 
not appear to provide any additional insights into this 
mechanism. For more information on the role of poly 
P in VBNC formation in C. jejuni, refer to the review by 
Kassem et al[39].
PPKs: Role in antimicrobial resistance and natural 
transformation
C. jejuni is increasingly becoming resistant to 
several clinically-relevant antimicrobials[41-43]. Two 
recent studies demonstrated that both ppk1 and 
ppk2 mutants were more susceptible to several 
antimicrobials (erythromycin, cefotaxime, ciprofloxacin, 
rifampin, polymyxin, and tetracycline) compared 
to their respective wildtypes[25,27]. The stringent-
response mediator ppGpp affects bacterial resistance 
to antimicrobials[44]; studies looking at ppGpp levels 
in the ppk1 mutant would provide some insights 
on this mechanism. Both ppk1 and ppk2 mutants 
had altered outer membrane profiles, suggesting 
that membrane permeability of these mutants 
may be compromised[45]; where altered membrane 
permeability could be the cause of increased 
susceptibility of ppk mutants to antimicrobials. Stress 
resistance is an emerging mechanism of antimicrobial 
resistance in bacteria[44]; thus, the susceptibility of ppk 
mutants to antimicrobials may also be explained by 
their general sensitivity to other stresses. In E. coli, 
poly P is known to regulate adaptive evolution and 
ribosome fidelity, both of which modulate resistance to 
antimicrobials[46]. Whether these mechanisms play a 
role in PPK1-mediated resistance to antimicrobials in C. 
jejuni also need to be investigated.
C. jejuni is naturally competent (i.e, ability to take 
up DNA from its surroundings) and this feature impacts 
the organism’s ability to adapt to different environments 
as well as to acquire antimicrobial resistance genes. 
Gangaiah et al[25] showed that a ppk1 mutant was 
compromised in its ability to acquire foreign DNA for 
natural transformation. Poly P is a component of the 
membrane channels that mediate DNA uptake[47,48]; 
the potential of such a mechanism for PPK1 to mediate 
natural competence in C. jejuni should be explored. 
Evidence suggests that outer membrane composition of 
the ppk1 mutant is altered[45]; whether this influences 
the ability of C. jejuni to take up DNA is also unknown.
PPKs: Role in motility and biofilm formation
Several recent studies have evaluated the role of 
PPKs in virulence-associated phenotypes such as 
motility, biofilm formation, adherence, invasion, and 
intracellular survival[24,25,27,45]. Motility is an essential 
C. jejuni virulence mechanism[49]. Three independent 
studies demonstrated that both PPK1 and PPK2 were 
not required for C. jejuni motility[24,25,27]. This is in 
contrast to other organisms, where PPK1 is required 
for motility. Surprisingly, Chandrashekhar et al[32] 
demonstrated that several flagella-associated genes 
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and flagellar glycosylation genes were downregulated 
in the ppk mutants; the authors hypothesized that the 
degree of downregulation in the ppk mutants may not 
have been enough to impair motility. Although motility 
was not affected by PPKs in C. jejuni, the potential role 
of PPKs on other phenotypes associated with flagella 
such as autoagglutination, secretion, and/or invasion 
needs further investigation.
Biofilms play an important role in C. jejuni tole-
rance to environmental stresses, disinfectants, and 
antimicrobials, as well as facilitating colonization of 
animal and human hosts[50-52]. Two independent groups 
demonstrated that the ppk1 mutant formed higher 
amount of biofilms than the wildtype[24,25]. This finding is 
in contrast to other organisms, where PPK1 is required 
for biofilm formation[13]. In another study, Gangaiah et 
al[27] demonstrated that ppk2 mutant also formed higher 
amount of biofilms than its parent. Drozd et al[53] went 
onto characterize how PPK enzymes modulate biofilm 
formation in C. jejuni and demonstrated that ppk1 and 
ppk2 mutants formed higher adherent colonies on day 
1 and 2 compared to wildtype. This study suggested 
that, compared to mutant strains, the wildtype might 
spend more time in planktonic phase, delaying biofilm 
formation[53]. The authors further demonstrated that 
ppk1 and ppk2 mutants had reduced calcofluor white 
reactivity, suggesting that polysaccharide structures 
might be altered in the mutant strains[53]. The quorum 
sensing molecule Autoinducer-2, which is required for 
biofilm formation, was increased in both mutants[53]. 
Finally, the authors evaluated the mutants for altered 
expression of genes involved in biofilm formation and 
found that several genes (pglH, kpsM, cj0688, neuB1, 
neuB1, fliS, and maf5) involved in biofilm formation 
were altered in ppk1 and ppk2 mutants[53].
PPKs: Role in adherence, invasion and intracellular 
survival
Adherence, invasion, and intracellular survival are 
also essential virulence mechanisms for C. jejuni[54]. 
Recent studies demonstrated that both PPK1 and PPK2 
are important for invasion and intracellular survival 
within INT-407 human intestinal epithelial cells[24,25,27]. 
Pina-Mimbela et al[45] showed that ppk1 and ppk2 
mutants had qualitative and quantitative differences in 
outer membrane composition compared to wildtype. 
They also demonstrated that the differences in outer 
membrane composition in the mutants were directly 
related to the ability of C. jejuni to invade and survive 
within INT-407 cells[45]. The authors of this study went 
one step further to evaluate which fractions were 
associated with invasion and intracellular survival[45]. 
They found that outer membrane proteins were 
uniquely associated with invasion, whereas outer 
membrane proteins, lipids, and lipoglycans all were 
associated with intracellular survival[45].
PPKs: Role in chicken colonization
Two independent studies evaluated the role of PPK1 in 
C. jejuni colonization in day-old chicks (Table 3)[24,25]. 
Candon et al[24] demonstrated that, after 7 days of 
oral inoculation, the wildtype colonized the ceca of 
chicks at a minimum average of 1.79 × 108 CFU/g 
of cecal contents at all inoculation doses examined. 
The ppk1 mutant colonized the ceca of all chicks at 
a rate similar to that of wildtype at a dosage of 1.5 
× 107 CFU/chick, of 8 out of 10 chicks at a dosage 
of 1.5 × 106 CFU/chick, and of 0 out of 10 chicks 
at a dosage of 1.5 × 105 CFU/chick[24]. In another 
study, Gangaiah et al[25] evaluated the role of PPK1 
in colonization of ceca and bursa as well as C. jejuni 
load in feces using low inoculation doses i.e., 103, 104, 
and 105 CFU/chick. They demonstrated that, after 8 
d of oral inoculation, the ppk1 mutant colonized the 
ceca and bursa and showed a C. jejuni load in feces 
of all chicks but at a significantly lower rate than the 
wildtype at a dosage of 105 CFU/chick[25]. While the 
wildtype colonized to an average of about 1.0 × 108 
CFU/g of ceca and about 1.0 × 105 CFU/g of bursa, 
and showed a C. jejuni load of about 1.0 × 107 CFU/
g of feces, none of the chicks were colonized with 
the mutant strain at a dosage of 104 CFU/chick[25]. 
Similarly, while the wildtype colonized to an average 
of about 1.0 × 106 CFU/g of ceca and about 1.0 × 
Table 3  Summary of chicken colonization phenotypes of ppk1  and ppk2  mutants
Study Organ/
feces
Inoculation dose 
(CFU/chick)
Wildtype 
(CFU/g)
ppk1  mutant (No. of chicks colonized) ppk2  mutant (No. of chicks colonized)
Candon et al[24] 
2007
Ceca 1.5 × 105 1.8 × 108 0/10 chicks NS
1.5 × 106 1.8 × 108 8/10 chicks NS
1.5 × 107 1.8 × 108 10/10 chicks at an average of 1.8 × 108 CFU/g NS
Gangaiah et al[25] 
2009 and 2010
Ceca 1.0 × 103 1.0 × 106 0/5 chicks 0/5 chicks
1.0 × 104 1.0 × 108 0/5 chicks 0/5 chicks
1.0 × 105 8.0 × 108 5/5 chicks at an average of 2.0 × 104 CFU/g 5/5 chicks at an average of 9.0 × 103 CFU/g
Bursa 1.0 × 103 1.0 × 104 0/5 chicks 0/5 chicks
1.0 × 104 1.0 × 105 0/5 chicks 0/5 chicks
1.0 × 105 1.5 × 105 5/5 chicks at an average of 1.0 × 102 CFU/g 5/5 chicks at an average of 8.0 × 102 CFU/g
Feces 1.0 × 103 1.0 × 105 0/5 chicks 0/5 chicks
1.0 × 104 1.0 × 107 0/5 chicks 0/5 chicks
1.0 × 105 3.0 × 107 5/5 chicks at an average of 1.5 × 103 CFU/g 5/5 chicks at an average of 8.0 × 103 CFU/g
NS: Not studied.
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104 CFU/g of bursa, and showed a C. jejuni load of 
about 1.0 × 105 CFU/g of feces, none of the chicks 
were colonized with the mutant strain at a dosage of 
103 CFU/chick[25]. Except for 105 CFU/chick, the two 
studies used different dosages for inoculation. Both 
studies were done in the same strain background; 
thus, the reason for the difference in the results 
between the two studies is unclear.
Furthermore, Gangaiah et al[27] evaluated the role 
of PPK2 in colonization of ceca and bursa as well in C. 
jejuni load in feces using 103, 104, and 105 CFU/chick 
inoculation doses (Table 3). They demonstrated that, 
at 105 CFU/chick inoculation dose, the ppk2 mutant 
colonized the ceca and bursa as well as showed a C. 
jejuni load in feces of all chicks but at a significantly 
lower rate than the wildtype[27]. While the wildtype 
colonized to an average of about 1.0 × 108 CFU/g of 
ceca and about 1.0 × 105 CFU/g of bursa, and showed 
a C. jejuni load of about 1.0 × 107 CFU/g of feces, 
none of the chicks were colonized with the mutant 
strain at a dosage of 104 CFU/chick, except for 1 
chick[27]. Similarly, while the wildtype colonized to an 
average of about 4.0 × 106 CFU/g of ceca and about 
1.0 × 104 CFU/g of bursa, and showed a C. jejuni load 
of about 1.0 × 105 CFU/g of feces, none of the chicks 
were colonized with the mutant strain at a dosage of 
103 CFU/chick[27]. 
It is intriguing that both ppk1 and ppk2 mutants 
behave similar with respect to chicken colonization. 
Several C. jejuni genes have been identified to be 
important for chicken colonization[55]; transcriptome 
and outer membrane proteome analyses showed that 
these genes did not appear to be regulated by PPK1 
and PPK2[32,45]. Thus, the mechanisms underlying 
the contribution of poly P to chicken colonization are 
unclear. Both ppk1 and ppk2 mutants showed dose-
dependent colonization defects in day-old chicks[24,25,27]. 
The authors hypothesized that the dose-dependency 
may be related to the hyperbiofilm phenotype of ppk1 
and ppk2 mutants[24,25,27]. According to this hypothesis, 
at lower inoculation doses, the ppk mutants are 
more sensitive to in vivo stresses and thus, display 
no or reduced colonization. At higher doses, the ppk 
mutants form hyperbiofilms, conferring resistance to 
in vivo stresses and thus, similar colonization of the 
mutants as that of wildtype. Additional in vivo studies 
complementing the mutants to rule out the effect of 
secondary mutations on colonization are warranted.
PPX/GPPA ENZYMES: ROLE IN C. JEJUNI 
SURVIVAL AND VIRULENCE
Malde et al[29] demonstrated that mutations in 
ppx/gppa genes were associated with a variety of 
phenotypes in C. jejuni. In this study, it was shown 
that ppx/gppa mutants were deficient in survival under 
nutrient limitation and osmotic stress. The authors 
further showed that the nutrient survival defect in 
the mutants could be complemented by amino acid 
supplementation. Based on these findings, it was 
hypothesized that the nutrient survival phenotype 
in the mutants is likely due to reduced ppGpp or 
increased poly P levels. Both ppx/gppa mutants had 
increased poly P levels; however, only ppx1/gppa 
mutant had reduced ppGpp levels when compared 
to wildtype but not ppx2/gppa mutant, which indeed 
accumulated more ppGpp than the wildtype[29]. This 
suggests that the nutrient survival defect in the 
mutants is more likely due to increased poly P levels 
rather than due to reduced ppGpp levels. 
Further, Malde et al[29] also demonstrated that 
ppx/gppa mutants were compromised in several 
virulence-associated phenotypes such as motility, 
biofilm formation, and invasion and intracellular 
survival within human intestinal epithelial cells. Unlike 
ppk1 and ppk2 mutants, which had similar motility as 
the wildtype, the ppx/gppa mutants were defective in 
motility compared to wildtype. The ppx/gppa mutants 
also had decreased ability to form biofilms. Poly P is 
essential for chelation of cations[13], which are required 
for biofilm formation[56]; whether such a mechanism is 
the cause of reduced biofilms in ppx/gppa mutants is 
an interesting question. The group further went on to 
test the contributions of PPX/GPPA enzymes to serum 
resistance and demonstrated that ppx/gppa mutants 
were resistant to human complement but not to 
chicken complement.
Although the contributions of PPX/GPPA enzymes 
to C. jejuni biology is well characterized at the 
phenotypic level using in vitro assays, it remains to be 
understood if these contributions impact colonization 
of C. jejuni in day-old chicks and infection in humans. 
The mechanisms underlying the PPX/GPPA-associated 
phenotypes are also largely unknown; a transcriptome 
analysis of the ppx mutants would provide some 
insights on this aspect. In other bacteria, it has been 
shown that excess poly P in the ppx mutants restricts 
growth and downregulates metabolism, which is 
thought to have caused the underlying phenotypes[57]. 
The C. jejuni ppx/gppa mutants grew very similar to 
the wildtype strain, yet were compromised in several 
phenotypes (i.e., motility, biofilm formation, nutrient 
stress survival, invasion and intracellular survival, and 
resistance to human complement-mediated killing), 
suggesting that growth restriction and metabolic 
downshift are less likely the reasons for PPX-dependent 
phenotypes in C. jejuni. Phenotypes associated with 
excess of poly P were modest compared to those 
associated with poly P deficiency, suggesting that lack 
of poly P impacts C. jejuni biology more than excess of 
poly P. It is also intriguing to note that the phenotypes 
of the double mutant lacking both ppx1/gppa and 
ppx2/gppa genes were more severe compared to 
those of the individual mutants, suggesting some 
degree of functional redundancy in these enzymes; 
the reason behind this functional redundancy is 
unclear. Overall, findings from the analysis of ppx/
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gppa mutants suggest that poly P levels are tightly 
regulated and that dysregulation of poly P levels as 
seen in the ppx/gppa mutants compromises C. jejuni’s 
survival and virulence properties.
LINK BETWEEN POLY P AND (P)PPGPP 
METABOLISM IN C. JEJUNI
Malde et al[29] assessed the role of PPX/GPPA enzymes 
in ppGpp synthesis and demonstrated that PPX1/GPPA 
but not PPX2/GPPA is important for ppGpp synthesis. 
In another study, Candon et al[24] demonstrated that 
a spoT mutant, which is deficient in ppGpp synthesis, 
had significantly reduced poly P levels than its parent. 
These findings suggest that (p)ppGpp and poly P 
metabolism are linked in C. jejuni (Figure 1). Both, 
(p)ppGpp and poly P metabolism are known to be 
linked in E. coli; in this organism, ppGpp is known to 
modulate poly P levels by inhibiting PPX enzymes[58,59]. 
Analogous to E. coli, the authors speculated that 
(p)ppGpp might modulate poly P levels in C. jejuni by 
inhibiting PPX enzymes, which would not only affect 
the dynamic balance between poly P degradation by 
PPX enzymes but also affects poly P synthesis by PPK1. 
However, this hypothesis remains to be experimentally 
confirmed. In Pseudomonas aeruginosa, PPK2 affects 
(p)ppGpp accumulation; this role of PPK2 is attributed 
to its ability to serve as a source of GTP, which is a 
precursor for (p)ppGpp synthesis[60]. However, a C. 
jejuni ppk2 mutant accumulated similar (p)ppGpp 
levels to that of wildtype, suggesting that PPK2 is 
less likely the link between poly P and (p)ppGpp 
metabolism in C. jejuni. Although PPK1 does not 
appear to have ppGpp synthetic/hydrolytic activity, 
it remains to be understood if (p)ppGpp levels are 
altered in the ppk1 mutant.
POLY P AND PHOSPHATE METABOLISM 
Inorganic phosphate (Pi) is an essential nutrient 
for many bacterial species. As most natural 
environments are limiting in Pi, phosphate esters are 
the preferred source of Pi for bacteria[61]. Phosphate 
esters are broken down into Pi in the periplasm by 
alkaline phosphatase. PhoAcj is the only alkaline 
phosphatase in C. jejuni[62]. Drozd et al[53] recently 
demonstrated that a phoAcj mutant had significantly 
reduced intracellular poly P levels compared to its 
parent, suggesting that PhoAcj is likely the primary 
source of Pi for poly P synthesis[53,63]. The authors 
also demonstrated that the phoAcj mutant had a 
significantly reduced ability to survive under nutrient 
stress, to invade and survive within INT407 cells 
and to colonize day-old chicks[63]. The phenotypes 
in the phoAcj mutant were in general less severe 
when compared to those in the ppk1 mutant. This is 
likely due to the fact that phoAcj mutant only had a 
modest defect in poly P accumulation compared to the 
ppk1 mutant, which had a severe deficiency in poly 
P accumulation[63]. Unlike ppk1 mutant, the phoAcj 
mutant had enhanced resistance to antimicrobials, 
suggesting that this phenotype is less likely due to poly 
P deficiency[63].
PHENOTYPIC OVERLAP BETWEEN POLY 
P AND RELATED ENZYMES
Several phenotypes of PPK1, PPK2, PPX/GPPA, SpoT, 
and PhoAcj enzymes overlap between each other 
as shown in Table 2[24,25,27,29,34,63,64]. For example, 
osmotic shock survival and low nutrient stress survival 
phenotypes were common to PPK1, PPK2, PPX/
GPPA, and PhoAcj enzymes. Similarly, intraepithelial 
survival phenotype was common to all enzymes and, 
except for PPK1, invasion was also common to all 
the enzymes. There are two possible explanations 
for this overlap; the enzymes likely affect the shared 
phenotypes independently, or the enzymes might 
impact the phenotypes through a common protein or 
molecule. As PPK2 is required for poly P-dependent 
GTP synthesis, it is conceivable that poly P deficiency 
in the ppk1 mutant likely also affects GTP levels[25,27]. 
Thus, the phenotypic overlap between PPK1 and 
PPK2 may be the consequence of low GTP levels in 
these mutants. Both spoT and phoAcj mutants had 
low poly P levels[34,63]; thus, the phenotypic overlap 
between PPK1, PhoAcj, and SpoT may be due to 
low poly P in these mutants. The ability to form 
biofilms was upregulated in the ppk1 mutant[24,25], 
which has low poly P levels, and downregulated in 
ppx/gppa mutants[29], which have high poly P levels; 
this suggests that the biofilm phenotype is directly 
associated with poly P. This is further supported by 
the fact that spoT mutant, which has low poly P, also 
formed more biofilms than its parent[34]. However, 
the ppk2 mutant, which has similar poly P levels as 
its parent, also formed more biofilms compared to 
its parent[27]; suggesting that the effect of PPK2 on 
biofilm formation is independent of poly P. Further 
studies are required to precisely define phenotypic 
overlap between poly P and related enzymes. For 
example, if the biofilm phenotype of the spoT mutant 
is due to low poly P levels, supplementation with 
poly P might rescue the biofilm phenotype in this 
mutant. Similarly, if the phenotypic overlap between 
ppk1 and ppk2 mutants is due to altered GTP levels, 
supplementation with GTP might rescue the associated 
phenotypes in the ppk1 mutant. Strains containing 
mutations in multiple of these enzymes accompanied 
by complementation may also provide insights as 
to whether these enzymes have a synergistic or 
antagonistic effect on the overlapping phenotypes.
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PPKS AS PROMISING DRUG AND 
VACCINE TARGETS
PPK enzymes have the potential to be ideal drug 
targets for controlling C. jejuni and other bacterial 
infections. First, these enzymes are highly conserved 
across a broad array of bacterial species[13]; thus, the 
identified drugs will be effective against many bacterial 
species. Second, homologs of PPKs are absent in 
higher eukaryotes[13]; thus, it is less likely that the 
drugs will be toxic to host cells. Third, a recent study 
by Pina-Mimbela et al[45] showed that PPKs modulate 
outer membrane composition of C. jejuni; thus, anti-
PPK drugs could expose surface antigens, which are 
otherwise hidden, and make C. jejuni vulnerable 
to host defense mechanisms. Fourth, deletion of 
ppk1 and ppk2 does not affect growth of bacteria in 
vitro[24,25,27]; thus, there is less selection pressure on 
the bacteria to develop resistance to anti-PPK drugs. 
Lastly, ppk mutants are more sensitive to several 
conventional antibiotics[24,25,27]; thus, anti-PPK drugs 
could be used in conjunction with existing antibiotics 
for drug-resistant strains.
Mutants of poly P enzymes could also be sought as 
potential live attenuated vaccine candidates. Strains 
with deleted virulence genes have been successfully 
used for controlling Salmonella colonization in 
poultry[65,66]. To have a synergistic effect on virulence/
colonization attenuation, mutants containing deletions 
in ppk genes and other established virulence 
determinants could be used. As discussed before, 
using ppk mutants as live attenuated vaccine can-
didates not only has the advantage of the strain being 
attenuated for colonization but also could expose 
previously hidden antigens, likely inducing a strong 
protective immunity.
Epidemiological studies have shown that nearly 
50%-80% of the human infections originate from 
ingestion of poultry and poultry products[4]. Both PPK1 
and PPK2 are necessary for C. jejuni colonization 
in chickens[4,24,25,27]. These data suggest that PPKs 
could at least be targeted for controlling C. jejuni 
colonization in chickens, which likely would aid in 
reducing human infections. A human challenge 
model is available to study campylobacteriosis using 
the C. jejuni strain CG8421, which lacks ganglioside 
mimicry, a mechanism known to cause Guillain Barre 
Syndrome[67-69]. The potential of using PPKs as drug 
and vaccine targets for human infections warrants 
that the contributions of these enzymes to human 
infection be studied using the human challenge model 
of campylobacteriosis. 
CLOSING REMARKS AND PERSPECTIVES 
Recent studies have yielded several important insights 
into the role of poly P in C. jejuni biology. Poly P is 
associated with a plethora of C. jejuni phenotypes, 
which not only impact how C. jejuni survives in the 
environment under different stress conditions but also 
impact how this organism colonizes poultry and other 
domestic animals and causes disease in humans. 
Transcriptome and outer membrane proteomics 
analyses of the ppk1 and ppk2 mutants have provided 
some valuable mechanistic insights with regards 
to poly P-associated phenotypes. Nevertheless, 
our understanding of poly P in C. jejuni is still in its 
first steps. For example, the signals that activate 
poly P-mediated response are largely unknown. 
Most bacteria, including C. jejuni, contain two PPX 
enzymes; the reason behind this redundancy is an 
open question. Although transcriptome and outer 
membrane proteomic studies have yielded valuable 
insights into poly P functions, the few genes or 
proteins differentially expressed in the ppk mutants 
compared to wildtype do not seem to explain the 
plethora of phenotypes arising from mutants of poly 
P-associated enzymes. This suggests that poly P may 
also mediate its functions by affecting its targets 
posttranscriptionally; global proteomic analyses of 
the ppk1 and ppk2 mutants will likely shed some 
light on this aspect. It is also not known how poly P 
is regulated; in other words, what are the upstream 
components that feed into poly P-mediated response? 
How poly P feeds into the global regulatory network 
also remains to be understood. Poly P and ppGpp are 
linked in C. jejuni and other bacteria but the precise 
mechanisms underlying their interaction are poorly 
understood. 
Given that poly P-related enzymes affect numerous 
aspects of C. jejuni life, these enzymes have the 
potential to be promising drug and vaccine targets. 
Therefore, it would be worthwhile to determine the 
contributions of poly P-related enzymes in a human 
model of Campylobacter infection. Gaynor et al[34] 
demonstrated that ppk1 was upregulated during C. 
jejuni infection of human intestinal epithelial cells. 
Thus, studies defining at which stage of human 
infection and chicken colonization the poly P-mediated 
response is activated would provide additional insights 
into its role in C. jejuni pathogenesis/colonization. 
The recent finding that Poly P enzymes modulate IL-8 
production in INT-407 cells suggests that host immune 
response to the mutant strains may be critical to 
study[45]. Such studies could facilitate development of 
ppk mutants alone or in combination with mutations 
in other established virulence genes as live attenuated 
vaccines for reducing C. jejuni colonization in poultry 
and one day for controlling human infections.
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